Skip to content
healthcare.dev

roflumilast

NDC 73190-087, ROFLUMILAST, tablet, from AvKARE.

Product NDC
73190-087
Status
Listed
Labeler
AvKARE
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208247
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73190-087 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
73190-087-307319000873030 TABLET in 1 BOTTLE (73190-087-30)
73190-087-907319000879090 TABLET in 1 BOTTLE (73190-087-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/55009549-3f0c-1f58-e063-6294a90a6c03

Use it

Look up 73190-087 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73190-087 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73190-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.